Trials Sponsors Conditions Drugs Pricing

Conditions

Mammary Gland Hyperplasia

Keywords

Mammary gland hyperplasiaLiver Qi stagnation

Outcome Measures

Primary Outcomes (1)

Relief Rate of Mammary Gland Pain
To clarify the effectiveness of Rugshengsheng No.1 Recipe in the Affiliated Hospital of Qinghai University in reducing the pain of patients with liver-stagnation and qi stagnation type breast hyperplasia, as well as related adverse side effects, and provide reliable clinical evidence for further clinical promotion
12 weeks

Secondary Outcomes (2)

Relief time of breast pain
12 weeks
Related adverse reactions
12 weeks

Study Arms (2)

study groups

EXPERIMENTAL

The study group was treated with Rugdenzengsheng No. 1 prescription for 2 courses.

Drug: Rugdenzengsheng No. 1 prescription

control groups

NO INTERVENTION

The control group was treated with observational treatment and follow-up in outpatient clinic.

Interventions

Rugdenzengsheng No. 1 prescriptionDrug

The study group was treated with the No. 1 Mammary Gland Growth Recipe orally, a total of 1 course of treatment, each course of 14 days, avoiding the menstrual period. The specific composition of Mammary Gland Hyperplasia No. 1 Recipe: Angelica 10g, Radix Paeoniae Alba 10g, Atractylodes Macrocephala 10g, Ginger 3g, Peppermint 6g, Vinegar Green Peel 6g, Lychee Seed 12g, Tangerine Seed 10g, Corydalis 10g, Fritillaria 6g, Trichosanthis 10g, Kombu 20g , Mustard seeds 10g, Moutan bark 6g, Poria 10g, North Bupleurum 6g. Method of administration: 14 doses in total, taken twice a day. The medicine is formulated in the herbal medicine room of the Affiliated Hospital of Qinghai University, with strict quality control.

Also known as: non

study groups

Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.

Eligibility Criteria

Age18 Years - 80 Years

Sexfemale(Gender-based eligibility)

Gender Eligibility DetailsAdult healthy women over 18

Healthy VolunteersNo

Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

Healthy women over 18 years of age;

Sponsors & Collaborators

Jiuda Zhao
Otherlead

Study Sites (1)

Qinghai University Affiliated Hospital

Qinghai, Xining, Qinghai, 810000, China

RECRUITING

Zhao Jiuda, MDCONTACT13327661976 jiudazhao@126.com

Study Design

Study Type: interventional
Phase: phase 2
Allocation: RANDOMIZED
Masking: QUADRUPLE
Who Masked: PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Masking Details: The study group took the No.1 Recipe for Rugden Zengsheng, and the control group took clinical observation and follow-up at the breast center. The study group and the control group were grouped randomly by envelope, and grouped according to 2:1.
Purpose: TREATMENT
Intervention Model: PARALLEL
Sponsor Type: OTHER
Responsible Party: SPONSOR INVESTIGATOR
PI Title: Professor

Study Record Dates

First Submitted

February 9, 2021

First Posted

February 23, 2021

Study Start

March 1, 2021

Estimated (date passed)

This estimate has passed. The registry has not confirmed an actual date for this milestone.

Clinical Trial of Ruxian Zengsheng No. 1 Decoction

Brief Summary

Registry Overview

Trial Relationships

Study Timeline

First Submitted

First Posted

Study Start

Primary Completion

Study Completion

Conditions

Keywords

Outcome Measures

Primary Outcomes (1)

Secondary Outcomes (2)

Study Arms (2)

study groups

control groups

Interventions

Eligibility Criteria

You may qualify if:

Sponsors & Collaborators

Study Sites (1)

Study Design

Study Record Dates

You may not qualify if:

Data Sharing

Source record

Locations

Brief Summary

Registry Overview

Trial Relationships

Related Scientific Literature

Study Timeline

First Submitted

First Posted

Study Start

Primary Completion

Study Completion

Conditions

Keywords

Outcome Measures

Primary Outcomes (1)

Secondary Outcomes (2)

Study Arms (2)

study groups

control groups

Interventions

Eligibility Criteria

You may qualify if:

Sponsors & Collaborators

Study Sites (1)

Study Design

Study Record Dates

You may not qualify if:

Data Sharing

Source record

Locations